MedTrace Logo

A Platform Study for solId orgaN CancERs

NCT05650125 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-08-01

No results posted yet for this study

Summary

Generating bespoke biosampling protocols for individual tumour specific translational projects is onerous, cumbersome and inefficient. This study aims to provide a broad platform to maximise the unique access to biopsy and resected tumour specimens available from cancer patients to provide a high-quality and efficient source of biosamples for specific translational projects. Access to historical FFPE samples and clinical data, as well as prospective fresh tissue samples, will allow interrogation of the underlying biology of these cancers. Matched pseudoanonymised clinical and radiological data will allow the development of rich high-yield datasets.

Conditions

Interventions

OTHER

Biosampling

Biosampling of blood/tumour/adjacent normal tissue

Sponsors & Collaborators

  • Countess of Chester NHS Foundation Trust

    collaborator OTHER

  • Liverpool University Hospitals NHS Foundation Trust

    collaborator OTHER_GOV

  • Clatterbridge Centre for Oncology

    collaborator OTHER

  • Liverpool Heart and Chest Hospital NHS Foundation Trust

    collaborator OTHER

  • Liverpool Womens Hospital

    collaborator UNKNOWN

  • University of Liverpool

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2030-01-01
Completion
2030-01-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05650125 on ClinicalTrials.gov